Literature DB >> 20652456

¹⁸F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with ¹⁸F-FDG PET and immunohistochemistry.

Go Miyashita1, Tetsuya Higuchi, Noboru Oriuchi, Yukiko Arisaka, Hirofumi Hanaoka, Hideyuki Tominaga, Satoshi Morita, Mitsuyuki Miyakubo, Tomohiro Ishikita, Yoshiki Nakasone, Akihide Negishi, Satoshi Yokoo, Keigo Endo.   

Abstract

OBJECTIVE: L-3-[¹⁸F]-fluoro-α-methyl tyrosine (FAMT) is transported into cancer cells by L: -type amino acid transporter 1 (LAT1). The purpose of the present study is to correlate the uptake of FAMT and FDG with the cellular proliferative activity measured by the Ki-67 labeling index (Ki-67 LI) in oral squamous cell carcinoma (OSCC).
METHODS: Twenty-five patients with OSCC were enrolled in this study. Both FAMT-PET and FDG-PET were performed within 4 weeks before surgery in all cases. The uptake of FAMT and FDG was compared by semiquantitative analysis with maximal standardized uptake values (SUVmax) of the primary tumors. Ki-67 LI of the tumors was analyzed by immunohistochemical staining and correlated with the clinicopathologic variables and the uptake of PET tracers.
RESULTS: For primary tumor detection, FAMT-PET exhibited a sensitivity of 84%, whereas that of FDG-PET was 88%. In all visible lesions, mean FDG uptake determined by average SUVmax was 9.7 (range 4.2-15.9) and mean FAMT uptake was 3.5 (range 1.3-8.5). The SUVmax of FAMT tended to show a better correlation with Ki-67 LI (r = 0.878) than that of FDG (r = 0.643).
CONCLUSIONS: Uptake of FAMT correlated with cellular proliferation of OSCC. FAMT-PET may be a useful procedure to evaluate tumor proliferation of OSCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20652456     DOI: 10.1007/s12149-010-0398-2

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  13 in total

1.  Preclinical characterization of 18F-D-FPHCys, a new amino acid-based PET tracer.

Authors:  Delphine Denoyer; Laura Kirby; Kelly Waldeck; Peter Roselt; Oliver C Neels; Thomas Bourdier; Rachael Shepherd; Andrew Katsifis; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-12-13       Impact factor: 9.236

2.  Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma.

Authors:  Aiko Nobusawa; Mai Kim; Kyoichi Kaira; Go Miyashita; Akihide Negishi; Noboru Oriuchi; Tetsuya Higuchi; Yoshito Tsushima; Yoshikatsu Kanai; Satoshi Yokoo; Tetsunari Oyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-26       Impact factor: 9.236

3.  Complementary roles of tumour specific PET tracer ¹⁸F-FAMT to ¹⁸F-FDG PET/CT for the assessment of bone metastasis.

Authors:  Motoho Morita; Tetsuya Higuchi; Arifudin Achmad; Azusa Tokue; Yukiko Arisaka; Yoshito Tsushima
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-05       Impact factor: 9.236

4.  Changes in the distributions of fluorine-18-labelled fluoro-2-deoxy-d-glucose accumulation into tongue-related muscles after dissection in patients with tongue cancer.

Authors:  Shinji Kito; Hirofumi Koga; Masafumi Oda; Tatsurou Tanaka; Ikuya Miyamoto; Masaaki Kodama; Manabu Habu; Shinya Kokuryo; Kenji Osawa; Noriaki Yamamoto; Shinobu Matsumoto-Takeda; Nao Wakasugi-Sato; Noriaki Kawanabe; Daigo Yoshiga; Shun Nishimura; Takaaki Joujima; Ayae Kito-Shingaki; Masataka Uehara; Masaaki Sasaguri; Yasuhiro Morimoto
Journal:  Dentomaxillofac Radiol       Date:  2017-06-20       Impact factor: 2.419

Review 5.  The role of L-type amino acid transporter 1 in human tumors.

Authors:  Yu Zhao; Lin Wang; Jihong Pan
Journal:  Intractable Rare Dis Res       Date:  2015-11

6.  Differentiation of malignant tumours from granulomas by using dynamic [(18)F]-fluoro-L-α-methyltyrosine positron emission tomography.

Authors:  Aiko Yamaguchi; Hirofumi Hanaoka; Yutaka Fujisawa; Songji Zhao; Kazutomo Suzue; Akihiro Morita; Hideyuki Tominaga; Tetsuya Higuchi; Hajime Hisaeda; Yoshito Tsushima; Yuji Kuge; Yasuhiko Iida
Journal:  EJNMMI Res       Date:  2015-04-30       Impact factor: 3.138

7.  Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-Analysis.

Authors:  Sheng-Ming Deng; Wei Zhang; Bin Zhang; Yin-Yin Chen; Ji-Hui Li; Yi-Wei Wu
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

8.  Synthesis and biological evaluation of O-[3-18F-fluoropropyl]-α-methyl tyrosine in mesothelioma-bearing rodents.

Authors:  I-Hong Shih; Fan-Lin Kong; Mohammad S Ali; Yinhan Zhang; Dong-Fang Yu; Xudong Duan; David J Yang
Journal:  Biomed Res Int       Date:  2013-07-09       Impact factor: 3.411

9.  Biological significance of fluorine-18-α-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer.

Authors:  S Suzuki; K Kaira; Y Ohshima; N S Ishioka; M Sohda; T Yokobori; T Miyazaki; N Oriuchi; H Tominaga; Y Kanai; N Tsukamoto; T Asao; Y Tsushima; T Higuchi; T Oyama; H Kuwano
Journal:  Br J Cancer       Date:  2014-03-25       Impact factor: 7.640

10.  Alterations in 18F-FDG accumulation into neck-related muscles after neck dissection for patients with oral cancers.

Authors:  S Kito; H Koga; M Kodama; M Habu; S Kokuryo; M Oda; K Matsuo; T Nishino; S Matsumoto-Takeda; M Uehara; D Yoshiga; T Tanaka; S Nishimura; I Miyamoto; M Sasaguri; K Tominaga; I Yoshioka; Y Morimoto
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.